Active, not recruitingNCT03583528
DOTATOC PET/CT for Imaging NET Patients
Studying Insulinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- British Columbia Cancer Agency
- Principal Investigator
- Francois Benard, MDBC Cancer
- Intervention
- 68Ga-DOTATOC PET/CT(diagnostic_test)
- Enrollment
- 800 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2018 – 2028
Study locations (1)
- BC Cancer, Vancouver, British Columbia, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03583528 on ClinicalTrials.gov